Joseph Araujo
Fundador en MINDSET PHARMA INC. .
Fortuna: 66 600 $ al 31/10/2023
Cargos activos de Joseph Araujo
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MINDSET PHARMA INC. | Director/Miembro de la Junta | 07/10/2019 | - |
Director Técnico/Científico/I+D | 07/10/2019 | - | |
Fundador | 07/10/2019 | - | |
CanCog Technologies, Inc.
CanCog Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services CanCog Technologies, Inc. operates as a contract research organization providing non-invasive research and development services in the companion animal market. The firm's services include food intake, cognitive assessment, activity and movement, imaging and special technologies. The company was founded by Norton William Milgram and David R. Stevens in 2002 and is headquartered in Toronto, Canada. | Director Ejecutivo | 01/03/2022 | - |
Fundador | 01/01/2002 | - | |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Director/Miembro de la Junta | - | - |
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Director/Miembro de la Junta | 16/09/2021 | - |
Historial de carrera de Joseph Araujo
Antiguos cargos conocidos de Joseph Araujo.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
InterVivo Solutions, Inc.
InterVivo Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services InterVivo Solutions, Inc. offers high-quality, translational drug discovery services to accelerate drug discovery programs to the clinic. The Canadian company provides a carefully selected array of neuroscience models and experiments to help propel new drugs forward through the development track. The private company's designed pharmacokinetics studies provide reliable data ensuring faster screening, selection, and development of lead candidates. The company has expertise in neurological disease models and laboratory testing capabilities to support emerging research. The company welcomes inquiries for novel approaches for model and bioanalytical development. Additionally, Transpharmation, a preclinical neuroscience CRO, relays a number of natural models of disease via the largest world-class canine colony in the industry. InterVivo Solutions can assist in discovering how they can help. | Director Ejecutivo | 01/01/2010 | 01/03/2023 |
Presidente | 01/01/2010 | 01/03/2023 | |
KARYOPHARM THERAPEUTICS INC. | Director/Miembro de la Junta | 22/12/2008 | 01/09/2010 |
Director Financiero/CFO | 22/12/2008 | 01/09/2010 | |
Fundador | 22/12/2008 | 01/09/2010 |
Formación de Joseph Araujo.
University of Toronto | Undergraduate Degree |
Estadísticas
Internacional
Canadá | 6 |
Estados Unidos | 2 |
Reino Unido | 2 |
Operativa
Director/Board Member | 4 |
Founder | 3 |
Chief Executive Officer | 2 |
Sectorial
Health Technology | 4 |
Commercial Services | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
MINDSET PHARMA INC. | Health Technology |
Empresas privadas | 4 |
---|---|
CanCog Technologies, Inc.
CanCog Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services CanCog Technologies, Inc. operates as a contract research organization providing non-invasive research and development services in the companion animal market. The firm's services include food intake, cognitive assessment, activity and movement, imaging and special technologies. The company was founded by Norton William Milgram and David R. Stevens in 2002 and is headquartered in Toronto, Canada. | Commercial Services |
InterVivo Solutions, Inc.
InterVivo Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services InterVivo Solutions, Inc. offers high-quality, translational drug discovery services to accelerate drug discovery programs to the clinic. The Canadian company provides a carefully selected array of neuroscience models and experiments to help propel new drugs forward through the development track. The private company's designed pharmacokinetics studies provide reliable data ensuring faster screening, selection, and development of lead candidates. The company has expertise in neurological disease models and laboratory testing capabilities to support emerging research. The company welcomes inquiries for novel approaches for model and bioanalytical development. Additionally, Transpharmation, a preclinical neuroscience CRO, relays a number of natural models of disease via the largest world-class canine colony in the industry. InterVivo Solutions can assist in discovering how they can help. | Commercial Services |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Commercial Services |
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Health Technology |
- Bolsa de valores
- Insiders
- Joseph Araujo
- Experiencia